Tenaya Therapeutics Inc Aktie News
0,75 $
1,22 %
gestern
Nasdaq,
26. Dezember, 22:05 Uhr
tracken
Tenaya Therapeutics Inc Aktie News
Neutral
GlobeNewsWire
●
15 Tage alt
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced the pricing of its underwritten public offering of 50,000,000 total units for gross proceeds of $60 milli...
Neutral
Seeking Alpha
●
15 Tage alt
Tenaya Therapeutics, Inc. (TNYA) Discusses Initial Data From RIDGE-1 Phase Ib/II Trial of TN-401 Gene Therapy for ARVC Prepared Remarks Transcript
Neutral
GlobeNewsWire
●
15 Tage alt
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that it intends to offer and sell units consisting of common stock and warrants to purchase shares of com...
Neutral
GlobeNewsWire
●
15 Tage alt
TN-401 was Well Tolerated at 3E13 vg/kg dose Robust Transduction and Demonstrated Increases in PKP2 Protein Levels in First Two Patients at Week 8 Clinically Meaningful Reductions in Arrhythmia Burden Observed in First Two Patients with More Than Six Months of Follow-Up Tenaya Management to Host a Webcast Conference Call Thursday, December 11 at 5:00 pm ET to Review Preliminary Results SOUTH S...
Neutral
GlobeNewsWire
●
15 Tage alt
MyPEAK-1 Protocol Amendments Agreed Upon with FDA; Tenaya Implementing Changes with Sites MyPEAK-1 Protocol Amendments Agreed Upon with FDA; Tenaya Implementing Changes with Sites
Neutral
Seeking Alpha
●
etwa 2 Monate alt
Tenaya Therapeutics, Inc. ( TNYA ) Shareholder/Analyst Call November 10, 2025 8:00 AM EST Company Participants Michelle Corral - Vice President of Investor Relationship & Corporate Communications Faraz Ali - CEO, Interim Principal Financial Officer & Director Whittemore G. Tingley - Chief Medical Officer Conference Call Participants Yasmeen Rahimi - Piper Sandler & Co., Research Division Michae...
Neutral
GlobeNewsWire
●
etwa 2 Monate alt
MyPEAK-1 Data Presented During Late-Breaking Session at AHA Scientific Sessions 2025 with Simultaneous Publication in Cardiovascular Research
Neutral
GlobeNewsWire
●
etwa 2 Monate alt
Oral Presentation on Saturday to Highlight Interim Safety and Efficacy Results from the MyPEAK™ -1 Phase 1b/2a Clinical Trial in Adults with MYBPC3-Associated Hypertrophic Cardiomyopathy
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
